SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-21-000104
Filing Date
2021-01-14
Accepted
2021-01-14 15:57:19
Documents
90
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm 10-Q 599350
2 CERTIFICATION lxrp_ex311.htm EX-31.1 9782
3 CERTIFICATION lxrp_ex312.htm EX-31.2 9750
4 CERTIFICATION lxrp_ex321.htm EX-32.1 4859
5 CERTIFICATION lxrp_ex322.htm EX-32.2 4656
12 lxrp_10qimg1.jpg GRAPHIC 1582
  Complete submission text file 0001640334-21-000104.txt   5107844

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lxrp-20201130.xml EX-101.INS 1013822
7 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20201130.xsd EX-101.SCH 93548
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20201130_cal.xml EX-101.CAL 46753
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20201130_def.xml EX-101.DEF 154917
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20201130_lab.xml EX-101.LAB 788758
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20201130_pre.xml EX-101.PRE 325598
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 21528731
SIC: 2834 Pharmaceutical Preparations